Utility of polyclonal antibodies targeted toward unique tryptic peptides in the proteomic analysis of cytochrome P450 isozymes

Toxicology in Vitro

Volumn 22, Issue 3, 2008, Pages 779-787

  Kornilayev, Boris A ^b   Alterman, Michail A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Anti peptide antibodies; CYP cytochrome(s) P450; MALDI TOF; Proteomics

Indexed keywords

CYTOCHROME P450; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; ISOENZYMES; MASS SPECTROMETRY; PEPTIDES; PROTEOMICS; RABBITS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPSIN;

EID: 40049111479     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.12.001     Document Type: Article

References (21)

1. Alterman, M.A., Kornilaev, B., Duzhak, T., Yakovlev, D. 2005a. Quantitative analysis of cytochrome P450 isozymes by means of unique isozyme-specific tryptic peptides: a proteomic approach combining mass spectrometry and immunochemistry. HUPO 4th Annual World Congress. Mol. Cell. Proteomics, p. S314.
2. Alterman M.A., Kornilayev B., Duzhak T., and Yakovlev D. Quantitative analysis of cytochrome P450 isozymes by means of unique isozyme-specific tryptic peptides: A proteomic approach. Drug Metab. Dispos. 33 (2005) 1399-1407
3. Anderson L., and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18 (1997) 533-537
4. Anderson N.L., Anderson N.G., Haines L.R., Hardie D.B., Olafson R.W., and Pearson T.W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Proteome Res. 3 (2004) 235-244
5. Chen G., Gharib T.G., Huang C.-C., Taylor J.M.G., Misek D.E., Kardia S.L.R., Giordano T.J., Iannettoni M.D., Orringer M.B., Hanash S.M., and Beer D.G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1 (2002) 304-313
6. Edwards R.J., Boobis A.R., and Davies D.S. A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies. Drug Metab. Dispos. 31 (2003) 1476-1480
7. Gelboin H.V., and Krausz K. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm. J. Clin. Pharmacol. 46 (2006) 353-372
8. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., and Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 1 (2002) 323-333
9. Guengerich F.P. Cytochromes P450, drugs, and diseases. Mol. Interv. 3 (2003) 194-204
10. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19 (1999) 1720-1730
11. Huber M., Bahr I., Kratzchmar J.R., Becker A., Mueller E.C., Donner P., Pohlenz H.D., Schneider M.R., and Sommer A. Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r. Mol. Cell. Proteomics 3 (2004) 43-55
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
13. Luss H., Li R., Shapiro R., Tzeng E., McGowan F., Yoneyama T., Hatakeyama K., Geller D., Mickle D., Simmons R., and Billiar T. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS. J. Mol. Cell. Cardiol. 29 (1997) 1153-1165
14. Murray G., Taylor M., Burke M., and Melvin W. Enhanced expression of cytochrome P450 in stomach cancer. Brit. J. Cancer 77 (1998) 1040-1044
15. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Ann. Rev. Pharmacol. Toxicol. 41 (2001) 297-316
16. Patterson L.H., and Murray G.I. Tumour cytochrome P450 and drug activation. Curr. Pharm. Des. 8 (2002) 1335-1347
17. Sisson T.H., and Castor C.W. An improved method for immobilizing IgG antibodies on protein A-agarose. J. Immun. Methods 127 (1990) 215-220
18. Tian Q., Stepaniants S.B., Mao M., Weng L., Feetham M.C., Doyle M.J., Yi E.C., Dai H., Thorsson V., Eng J., Goodlett D., Berger J.P., Gunter B., Linseley P.S., Stoughton R.B., Aebersold R., Collins S.J., Hanlon W.A., and Hood L.E. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol. Cell. Proteomics 3 (2004) 960-969
19. Uto I., Ishimatsu T., Hirayama H., Ueda S., Tsuruta J., and Kambara T. Determination of urinary Tamm-Horsfall protein by ELISA using a maleimides method for enzyme-antibody conjugation. J. Immun. Methods 138 (1991) 87-94
20. Webb T., Jackson P.J., and Morris G.E. Protease digestion studies of an equilibrium intermediate in the unfolding of creatine kinase. Biochem. J. 321 (1997) 83-88
21. Zimmerman D.H., Lloyd J.P., Heisey D., Winship M.D., Siwek M., Talor E., and Sarin P.S. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1SF2 p17) and peptide segments of human [beta]-2-microglobulin or MHC II [beta] chain. Vaccine 19 (2001) 4750-4759